| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| BHC Bausch Health Companies Inc. | 21,089,341,282.6 | 18,665,640,866.54 | 16,556,706,738.28 |
| TSHA Taysha Gene Therapies, Inc. | -1,272,442,718.43 | -1,272,411,241.8 | 5,547,157,766.53 |
| 6472 保瑞 | 688,938,000 | 454,238,000 | 3,696,457,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,615,506,495.5 | 1,345,090,777.66 | 1,658,031,420.99 |
| PSNL Personalis, Inc. | -811,152,723.66 | -930,197,333.71 | 641,304,834.76 |
| 3705 永信 | 327,770,000 | 208,390,000 | 563,414,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | -270,289,811.33 | -269,723,232.02 | 442,876,166.93 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| 6461 益得 | -85,138,000 | -98,472,000 | 44,980,000 |
| ASMB Assembly Biosciences Inc | -487,510,026.54 | -487,510,026.54 | 36,701,749.16 |
| CPHI China Pharma Holdings Inc | -1,033,377.72 | 4,293,412.17 | |
| 1720 生達 | 226,316,000 | 98,372,000 | -11,394,000 |
| 6130 上亞科技 | -9,023,000 | -9,023,000 | -13,697,000 |
| SUPN Supernus Pharmaceuticals, Inc. | -151,402,584.43 | -169,281,309.58 | -154,739,107.08 |
| 4120 友華 | -305,129,000 | -376,627,000 | -185,264,000 |
| 4747 強生* | 14,405,000 | 2,196,000 | -765,190,000 |
| RDY Dr. Reddy's Laboratories Limited | -308,566,178.85 | -1,448,962,865.71 | -1,387,715,641.43 |
| TEVA Teva Pharmaceutical Industries Limited | 12,968,371,057.36 | 9,663,325,035.46 | -2,706,990,075.08 |
| BBIO BridgeBio Pharma, Inc. | -2,238,019,782.89 | -2,251,963,929.44 | -6,357,712,434.24 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例